Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Janssen-Cilag Oy
OY
Active
Y-tunnus 0922140-8
Hatsinanpuisto 8B, 02600
Espoo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1993 · 33 years old
124 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Janssen-Cilag Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
187954B
140966B
93977B
46989B
-0.0B
2021: 0.2B
0.2B
2021
2022: 0.2B (-4% vs 2021)
0.2B
-4%
2022
2023: 13B (+7689% vs 2022)
13B
+7689%
2023
2024: 0.1B (-99% vs 2023)
0.1B
-99%
2024
2025: 150933B (+109371596% vs 2024)
150933B
+109371596%
2025
EBITDA
EUR millions
11085B
8313B
5542B
2771B
0B
2021: 0.0B
0.0B
2021
2022: 0.0B (+67% vs 2021)
0.0B
+67%
2022
2023: 0.0B (-30% vs 2022)
0.0B
-30%
2023
2024: 0.0B (0% vs 2023)
0.0B
0%
2024
2025: 8901B (+127160314% vs 2024)
8901B
+127160314%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
150 932 940 000
138 281
12 540 157
160 736
167 741
Staff expenses
−18 505 709 000
−18 095
−18 535
−18 575
−16 989
EBITDA
8 901 229 000
7 422
6 525
10 164
5 647
Depreciation & amort.
−358 264 000
−354
−1 037
−952
−891
EBIT
8 542 965 000
7 069
10 962 296
9 212
4 756
Net financials
−732 291 000
1 069
520
−4
−30
Profit before tax
7 810 674 000
8 137
6 009
9 207
4 726
Tax
103 050 000
1 855
1 550
2 174
1 197
Net profit
7 707 624 000
6 282
4 458
7 034
3 529
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
79 480
55 285
63 352
54 936
71 058
Equity
17 076
9 904
8 621
8 862
13 924
Long-term debt
0
0
0
2 418
2 962
Short-term debt
10 059
45 382
26 583
43 656
54 172
Total debt
62 404
45 382
54 731
46 074
57 134
Financial ratios
5-year trend
EBITDA margin
5,9 %
This company
15,8 %
Market median
This company
Market median
63% below market
2021
2025
Equity ratio
21,5 %
This company
38,2 %
Market median
This company
Market median
44% below market
2021
2025
Return on equity
>999 %
This company
18,4 %
Market median
This company
Market median
>999% above market
2021
2025
Net profit margin
5,1 %
This company
8,1 %
Market median
This company
Market median
37% below market
2021
2025
Asset turnover
>999×
This company
1,12×
Market median
This company
Market median
>999% above market
2021
2025
Debt / equity
3,65×
This company
0,62×
Market median
This company
Market median
489% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Janssen-Cilag Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
